ROCKET PHARMACEUTICALS, INC. Underwriting Agreements
11 Contracts & Agreements
- Underwriting Agreement, dated September 12, 2023, among Rocket Pharmaceuticals, Inc. and J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, Leerink Partners LLC and Cowen and... (Filed With SEC on September 15, 2023)
- Underwriting Agreement, dated October 3, 2022, among Rocket Pharmaceuticals, Inc. and Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC and SVB Securities LLC, as... (Filed With SEC on October 4, 2022)
- Underwriting Agreement, dated December 9, 2020, among Rocket Pharmaceuticals, Inc., J.P. Morgan Securities LLC, BofA Securities, Inc., SVB Leerink LLC and Piper Sandler & Co (Filed With SEC on December 11, 2020)
- Underwriting Agreement, dated December 10, 2019, among Rocket Pharmaceuticals, Inc., J.P. Morgan Securities LLC, Cowen and Company, LLC and Evercore Group L.L.C (Filed With SEC on December 13, 2019)
- Underwriting Agreement, dated April 15, 2019, among Rocket Pharmaceuticals, Inc., SVB Leerink LLC, Evercore Group L.L.C. and William Blair & Company, L.L.C (Filed With SEC on April 18, 2019)
- Underwriting Agreement, dated November 27, 2018, among Rocket Pharmaceuticals, Inc., Merrill Lynch, Pierce, Fenner & Smith Incorporated, Cowen and Company, LLC and Evercore Group... (Filed With SEC on November 29, 2018)
- Underwriting Agreement, dated January 24, 2018, among Rocket Pharmaceuticals, Inc., Cowen and Company, LLC and Evercore Group L.L.C (Filed With SEC on January 25, 2018)
- Inotek Pharmaceuticals Corporation 5.75% Convertible Senior Notes Due 2021 UNDERWRITING AGREEMENT (Filed With SEC on August 3, 2016)
- 4,500,000 InotekPharmaceuticals Corporation Common Stock UNDERWRITING AGREEMENT (Filed With SEC on August 10, 2015)
- Inotek Pharmaceuticals Corporation [ ]% Convertible Senior Notes Due 2020 UNDERWRITING AGREEMENT (Filed With SEC on January 22, 2015)
- [Number of Shares] Inotek Pharmaceuticals Corporation Common Stock UNDERWRITING AGREEMENT (Filed With SEC on January 22, 2015)
